8-KMaterial AgreementsOther EventsExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Material Agreement (Mar 25, 2011)

Filed March 25, 2011For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) filed an 8-K on March 25, 2011, primarily to report the issuance of a significant amount of senior notes. The company successfully closed a debt offering on March 24, 2011, raising a total of $1.45 billion across several tranches of senior unsecured notes. These notes include $300 million of 3.200% Senior Notes due 2016, $550 million of 4.700% Senior Notes due 2021, $200 million of 5.750% Senior Notes due 2040 (a further issuance), and $200 million of Floating Rate Senior Notes due 2014. This substantial debt issuance indicates a strategic move by Quest Diagnostics to manage its capital structure and potentially fund future operations or acquisitions. The company has entered into an indenture governing these notes, which includes covenants restricting certain actions such as creating liens, engaging in sale-leaseback transactions, and making restricted payments. Importantly, the indenture also mandates an offer to repurchase the notes at 101% of their principal amount plus accrued interest upon a change of control triggering event. The filing also references a press release from March 21, 2011, announcing the proposed offering, and details the underwriting agreement with several major financial institutions.

Key Highlights

  • 1Quest Diagnostics issued $1.45 billion in senior unsecured notes on March 24, 2011.
  • 2The notes are comprised of four series: 3.200% due 2016 ($300M), 4.700% due 2021 ($550M), 5.750% due 2040 ($200M), and Floating Rate due 2014 ($200M).
  • 3The 5.750% Senior Notes due 2040 represent a further issuance, building upon a previous offering in 2009.
  • 4The issuance was governed by an indenture with standard covenants limiting liens, sale-leaseback transactions, and restricted payments.
  • 5A 'change of control' provision requires the company to offer to repurchase the notes at 101% of par plus accrued interest.
  • 6The offering was underwritten by a syndicate of major financial institutions, including Morgan Stanley, Goldman Sachs, and others.
  • 7The filing also incorporates by reference a press release from March 21, 2011, announcing the proposed offering.

Frequently Asked Questions

Quest Diagnostics raised a total of $1.45 billion through the issuance of senior notes.

The company issued $300 million of 3.200% Senior Notes due 2016, $550 million of 4.700% Senior Notes due 2021, $200 million of 5.750% Senior Notes due 2040, and $200 million of Floating Rate Senior Notes due 2014.

The notes are senior unsecured obligations. The indenture includes covenants that restrict the company's ability to create certain liens or engage in specific transactions. Crucially, upon a 'change of control triggering event', the company is required to offer to purchase the notes at 101% of their principal amount plus accrued interest, providing a layer of protection in such scenarios.

The filing does not explicitly state the purpose of the debt issuance, but large debt offerings like this are typically used for general corporate purposes, refinancing existing debt, funding strategic initiatives, or financing acquisitions.